Literature DB >> 15189279

Progenitor cell activation in chronic viralhepatitis.

Anastasia Fotiadu1, Valentini Tzioufa, Eleni Vrettou, Dimitrios Koufogiannis, Constantine S Papadimitriou, Prodromos Hytiroglou.   

Abstract

BACKGROUND/AIM: Oval cell proliferation is known to occur in experimental models of hepatic regeneration and carcinogenesis. Recent studies have suggested that activation of progenitor cells, representing the human counterpart of oval cells, may play a role in hepatic diseases. Therefore, we evaluated putative progenitor cells in chronic viral hepatitis.
METHODS: Forty-one needle liver biopsy specimens from patients with chronic hepatitis B and 43 specimens from patients with chronic hepatitis C were examined histologically. The grade (histological activity index (HAI)) and stage (degree of fibrosis) were determined on routinely stained sections. The number of progenitor cells was assessed semiquantitatively on cytokeratin 7- (CK 7-) stained sections.
RESULTS: In both aetiological categories of chronic viral hepatitis, progenitor cell numbers were found to increase in parallel to the HAI, as well as to the stage of disease. Features suggestive of hepatocytic differentiation of progenitor cells were also noted on immunohistochemical stains for CK 7 and 'hepatocyte-specific' antigen.
CONCLUSIONS: In chronic hepatitis B and chronic hepatitis C, progenitor cell activation is correlated with the grade and stage of disease. Proliferating progenitor cells may play a role in hepatic regeneration occurring in this setting. Copyright 2004 Blackwell Munksgaard

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15189279     DOI: 10.1111/j.1478-3231.2004.00908.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  11 in total

1.  Hepatic progenitor cells in chronic hepatitis C: a phenomenon of older age and advanced liver disease.

Authors:  Johanna Delladetsima; Paraskevi Alexandrou; Konstantinos Giaslakiotis; Mina Psichogiou; Gregory Hatzis; Vana Sypsa; Dina Tiniakos
Journal:  Virchows Arch       Date:  2010-08-19       Impact factor: 4.064

2.  Immunohistochemical characterization of hepatic stem cell-related cells in developing human liver.

Authors:  Jun Xu; Yong Hu; Jian Wang; Ji Zhou; Taiping Zhang; Hongyu Yu
Journal:  Front Med China       Date:  2007-07

Review 3.  Evidence regarding a stem cell origin of hepatocellular carcinoma.

Authors:  Thomas Shupe; Bryon E Petersen
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

4.  Immune suppression uncovers endogenous cytopathic effects of the hepatitis B virus.

Authors:  Philip Meuleman; Louis Libbrecht; Stefan Wieland; Rita De Vos; Nagy Habib; Anna Kramvis; Tania Roskams; Geert Leroux-Roels
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

5.  Scopolamine treatment and muscarinic receptor subtype-3 gene ablation augment azoxymethane-induced murine liver injury.

Authors:  Sandeep Khurana; Nirish Shah; Kunrong Cheng; Brian Shiu; Roxana Samimi; Angelica Belo; Jasleen Shant; Cinthia Drachenberg; Jürgen Wess; Jean-Pierre Raufman
Journal:  J Pharmacol Exp Ther       Date:  2010-03-02       Impact factor: 4.030

6.  The CD133+CD44+ precancerous subpopulation of oval cells is a therapeutic target for hepatocellular carcinoma.

Authors:  Yun-Wen Zheng; Tomonori Tsuchida; Taiki Shimao; Bin Li; Takanori Takebe; Ran-Ran Zhang; Yu Sakurai; Yasuharu Ueno; Keisuke Sekine; Naoto Ishibashi; Makiko Imajima; Takuji Tanaka; Hideki Taniguchi
Journal:  Stem Cells Dev       Date:  2014-06-26       Impact factor: 3.272

7.  Successful Interferon Therapy Reverses Enhanced Hepatic Progenitor Cell Activation in Patients with Chronic Hepatitis C.

Authors:  Hidenao Noritake; Yoshimasa Kobayashi; Yukimasa Ooba; Erika Matsunaga; Kazuyoshi Ohta; Shin Shimoyama; Satoru Yamazaki; Takeshi Chida; Kazuhito Kawata; Takanori Sakaguchi; Takafumi Suda
Journal:  J Interferon Cytokine Res       Date:  2015-08-26       Impact factor: 2.607

8.  Ultrastructure of oval cells in children with chronic hepatitis B, with special emphasis on the stage of liver fibrosis: the first pediatric study.

Authors:  Maria Elzbieta Sobaniec-Lotowska Sobaniec-Lotowska; Joanna Maria Lotowska; Dariusz Marek Lebensztejn
Journal:  World J Gastroenterol       Date:  2007-06-07       Impact factor: 5.742

9.  HBx protein promotes oval cell proliferation by up-regulation of cyclin D1 via activation of the MEK/ERK and PI3K/Akt pathways.

Authors:  Heng-Yi Wang; Sheng-Li Yang; Hui-Fang Liang; Chang-Hai Li
Journal:  Int J Mol Sci       Date:  2014-02-26       Impact factor: 5.923

Review 10.  Hepatic progenitor cells in canine and feline medicine: potential for regenerative strategies.

Authors:  Hedwig S Kruitwagen; Bart Spee; Baukje A Schotanus
Journal:  BMC Vet Res       Date:  2014-06-19       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.